Toronto Stocks Edge Lower; Parkland Shares Up After Rebuffing Call for Strategic Review
By Adriano Marchese
Toronto-listed stocks started the week slightly lower midday Monday. On the macroeconomic side, manufacturing shipments in Canada rose 0.7% in February from the previous month to a seasonally adjusted 71.61 billion Canadian dollars ($51.98 billion), while wholesale trade was flat.
Sector performance was mixed in Canada, with gains mainly in distribution services, health services and commercial services offset by losses primarily in materials, energy and tech services.
Canada's S&P/TSX Composite Index at midday were trading 0.2% lower at 21867.81, and the blue-chip S&P/TSX 60 was down 0.1% at 1310.16.
Parkland's shares rose 4.9% to C$42.94 after the Canadian fuel retailer rejected a call from its largest shareholder to launch a strategic review of options, including a change in ownership.
Other market movers:
Canopy Growth shares fell by 5.6% to C$10.10 after it said it received shareholder approval to create and issue a new class of exchangeable shares as it looks to accelerate growth in the U.S. market.
Shares in Onex were 1.3% higher at C$97.91 after it said it plans to launch a share-repurchase program to buy back up to 10% of its issued and outstanding public shares over a one-year period.
Numinus Wellness shares fell 25% to C$0.08 after the mental health care company said it will consider divesting its Canadian clinical operations to focus on its U.S. business following a strategic review.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
April 15, 2024 12:18 ET (16:18 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track